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Technical Report
Abstract
Purpose: Several attempts have been made to increase the distance between theprostate and the rectum through injection of different synthetic compounds,generating space between organs. To report an original technique to increase thedistance between the rectum and the prostate, by autologous fat implantation intothe rectoprostatic space, with the aim of providing physical dosimetry protectionand rectal dose sparing. Methods: We prospectively evaluated twelve patientssubjected to autologous fat implantation as recto-prostatic spacer subsequentlyreceiving prostate either radical (n = 6), or salvage brachytherapy for localrecurrence after external beam radiation therapy (EBRT) (n = 6). Standardpermanent prostate brachytherapy seed implantation was performed throughtransperineal approach and under transrectal ultrasonography (TRUS) andtemplate guidance. Prescribed D90 dose for Iodine - 125 monotherapy was 140 -160 Gy, reduced by 30% for rescue cases to obtain a Rectum V100 under 1 cc.
Results: Lipo-transfer was completed in all 12 patients. Control CT scan at 1 monthshowed average distances of: 10.7 mm (range) (2.8 - 15.9 mm), 7.6 (1.8 - 11.6 mm)and 6.8 (4.2 - 8.3) mm at prostate base, middle and apex, respectively. Shortestseparation distance observed was at apex and midline, while largest was observedthe sides and at seminal vesicles level. Control CT at 3 months showed averagedistances of 9.6 mm (1.9 - 14.6 mm), 6.3 mm (1.8 - 10.2 mm) and 5.4 mm (3.8 - 7.2mm) at prostate base, middle and apex, respectively. Most complications wereminor. Conclusion: Autologous fat transfer is a feasible and simple procedure forexperienced practitioners with low complication rates, which allows doseescalation to the prostate.
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1. IntroductionSeveral phase III studies have now demonstratedconsistent improvement in tumor control usingradiation dose escalation. Increasing total radiation doseaugments risk of side effects, unless volume of normaltissue treated along with the tumor can be reduced.1, 2Direct link between dose and acute or chronic rectaltoxicity during prostate radiation treatment has beenwell established.3, 4, 5Many attempts have been made to increase the distancebetween the prostate and the rectum through injectionof different synthetic compounds generating a space
between both organs. Substances introduced mustremain stable during radiotherapy application.6, 7, 8 Useof materials has proven effective in reducing totalradiation dose to the rectum while minimizing toxicity.9Our group has developed a technique to increase thedistance between the rectum and the prostate, byautologous fat implantation into the rectoprostaticspace, with the aim of providing physical dosimetryprotection and rectal dose sparing.The objective of this study is to describe the technicalfeasibility of autologous fat implant as a prostatic rectalspacer and our early results in patients undergoing low
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dose rate prostate brachytherapy either for primary orsalvage treatment.
2. Methods and MaterialsWe prospectively evaluated twelve patients whounderwent autologous fat implantation aprostatic-rectal spacer to receive prostatebrachytherapy either as radical (n = 6), or salvagetreatment for local recurrence after external beamradiation therapy (EBRT) (n = 6). All patients signedspecific informed consent forms previously approved bythe institutional review board.
2.1. TechniqueFirst, standard permanent seed prostate brachytherapyimplantation was performed through transperinealapproach under transrectal ultrasonography (TRUS) andtemplate guidance. High-resolution biplanar ultrasoundwith dedicated prostate brachytherapy software wasused together with fluoroscopy monitoring of seeddeposition. After loading of stranded seeds, D90prescription dose used for Iodine-125 monotherapy was140 - 160 Gy, and reduced by 30% for salvage cases, Thegoal was to obtain Rectum V100 under 1 cc.10Fat extraction and processing was conducted by a plasticsurgeon experienced in lipo-transfer, and radioactiveseed and fat implants by an urologist with extensiveexperience in brachytherapy techniques. Dosimetry andplan approval was supervised by a radiation oncologist.The procedure applied for lipo transfer consists of thefollowing steps, originally described by Coleman.11
2.1.1. Infiltration of donor fatPeriumbilical subcutaneous cellular tissue is infiltratedwith 1 mg of adrenaline diluted in 500 ml of saline.Infiltration plane is the same as the one followed duringabdominal liposuction, in which a syringe or infiltrationpump may be used, with multi-perforated Klein needlesattached. Twenty minutes are necessary forvasoconstrictive effects to occur. A 10 cc Luer-Loksyringe is then used for fat aspiration at a negativepressure of 50 to 115 mm Hg, in order not to damage fatcells, filling a 3 mm cannula. The material is thenallowed to decant, and supernatant removed after tenminutes. Syringe contents are centrifuged at 1000 rpmfor three minutes; this time is brief and the speed low inorder to allow adipocyte concentration and separationfrom the remaining Klein solution only.Eighty ccs of subcutaneous abdominal fat need to beharvested, to generate 30 cc of finely processed fat.11
2.1.2. Fat transferOnce brachytherapy is completed, the transrectaltransducer is pushed down as far as possible in thedorsal direction, in order avoid compression of therectum against the prostate. A Foley catheter is left in
place to identify the midline. One cc of saline or sterilegel should be introduced into the tip of the Denonvilliersfascia to generate a welt using an 18 G brachytherapyneedle under physical placement grid guidance (Figure1A). This will create a window and make placement ofthe 3 mm placement needle easier, a step which can beavoided if necessary. However, much bettervisualization is obtained creating a gel or water welt.Water is easy to inject, but remain for less time than gel,which may be harder to introduce, but persist for longer.Dissection of Denonvilliers fascia is very simple inprimary cases, but may be more difficult in salvagecases, for which gel or water dissection is recommendedfirst.11
Figure 1: A: Dissecting Dennonvillers fascia with waterusing a standard 18 gauge needle. B: fat transfer withdedicated 3 mm needle.
Figure 2: Final axial US view of transferred fat andincreased prostate-rectum distance on the left side.
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The brachytherapy grid is then removed, and theperineal area scrubbed with an antiseptic, thetransducer is isolated and a 3 mm incision is made alongthe midline, at 10 mm from the anal verge. The transferneedle is then introduced freehand, parallel to thetransducer and connected to a fat-loaded 10 cc Luer-Loksyringe, tightly screwed and purged.11Great care should be taken not to injure the rectum,should this occur the procedure must be terminatedimmediately. Needle entry port is through the weltcreated by prior injection of gel or water. Small amountsof fat are introduced (1 ml), with the needle openingfacing either the rectum or the prostate, while advancing5 to 10 mm proximally, constantly rotating the needlebetween 12 and 6 o’clock (Figure 1B).This will generate small lakes of fat that will maximizeposterior nutrition. Notice this concept is the opposite ofthe procedure described by Coleman, whorecommended distal to proximal injection of smallvolumes. However, in cases of salvage brachytherapy theDenonvilliers fascia may be more adherent, therefore,distal to proximal dissection and fat injection is betterfor these cases. Semi-liquid fat is isoechoic, and care isrequired as natural planes of dissection may be lost,making spaces generated hard to visualize, particularlythe Denonvilliers fascia.
Figure 3: 1st and 3rd month CT Scan in a case of primarybrachytherapy. Prostate-rectum distance remained thesame at 3 months. Note, 3 separate small lakes: at midlineand on both sides.Once midline injection is completed, the needle is drawnback and redirected towards one side. The parallelposition between the needle and the longitudinaltransducer crystal is lost; therefore, transducer shouldbe used to monitor needle tip displacement control both
rectum location as well as fat injection site. Along thesides, the Coleman technique of distal to proximalinjection may be followed, advancing the needle aftereach injection, always rotating in order to generate smallfat welts. Once one side is completed, the procedure isrepeated on the opposite side.11It is important to alternate between ultrasound planes(longitudinal to axial) to better control the procedure(Figure 2). We have always attempted to generate adistance of at least 10 mm between the prostate and therectum. Ciprofloxacin is administered for antibioticprophylaxis.Control CT scan is obtained in all patients one and threemonths post procedure in order to measure the distancebetween the rectum and prostate at the base,midsection, and apex.
3. ResultsLipo-transfer was completed in all 12 patients. Six wereprimary cases and six salvage brachytherapy cases. Inthe rescue cases, a 30 ml fat implant was conducted onlyon the positive biopsy side (Figure 4). In standardbrachytherapy cases, 40 ml were placed bilaterally (20ml on each side).Two patients referred perineal heaviness but did notrequire medication (Clavien 1). No patients referredlower bowel dysfunction.
4. DiscussionIncidence of actinic proctitis after prostate treatment is5 - 20% according to the published series.3, 4, 5 Currently,in the era of modern radiation therapy modalities suchas three-dimensional conformal, intensity modulatedand image- guided radiotherapy technique this figurehas dropped to 1 - 3.8%12, 13 because of decreased rectalexposure. In cases of local recurrence (LR) after EBRT,rectal complication rates rise considerably (3 - 47%)and become potentially severe and difficult to manage.13Dose-volume histograms have been studied extensively,and the nature and timing of the radiation dose analyzedto provide safe maximum dosing to the cancerousprostate, while minimizing risk of late uncommon rectalcomplications after primary EBRT or brachytherapytreatment. Dose constraints after EBRT rectum D75 are< 5%, and D50 are < 20%. Similarly, for rectal dosimetryin brachytherapy the RV100 is ideally < 1 cc.2, 10However, rectal proximity to higher isodose lines makesit very difficult to remain within this ideal constraintlevel.5 This is why, rectal spacers generating an ideal 10mm separation were developed, ensuring better rectaldose sparing.14In salvage brachytherapy after prior EBRT, use of rectalspacers would potentially allow full dose treatments.
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Use of other modalities such as cryotherapy, HIFU (highintensity focused ultrasound) etc. requires furtherinvestigation.13 Synthetic spacers such as polyethyleneglycol (PEG) or hyaluronic acid (HA) have beendeveloped, with considerable reduction of rectumexposure.14, 6 Prada et al. reported mean rectal dosereduction from 608 to 442 cGy during HDR and LDRbrachytherapy, after generating a 20 mm separation byinjecting 6 (3 - 7) ml of HA.7 Strom evaluated use of PEGin 100 patients undergoing HDR brachytherapy with orwithout IMRT8 creating 12 ± 4 mm separation using 10ml of PEG and reducing D2 cc from 60 ± 8% to 47 ± 9%(p < 0.001). Heikilä used 10 ml of PEG decreasing rectaldose from 64 ± 13 Gy to 31 Gy (95 ± 13) (p < 0.005).Separation duration was reported to be 110 days.14Increasing the distance not only decreased risk of rectalside effects but also allowed greater dose delivery to theprostate. This is important for hypofractionated EBRTplanning.
Figure 4: CT Scan at 1st and 3rd month in two cases ofsalvage brachytherapy.
Coleman11 described the lipo-transfer technique fordamaged tissue repair, as a simple way to generate afilling effect and replace tissue loss. The procedure isbased on the presence of stem cells in the transferredfat. In fact, adipose tissue has the highest concentrationof stem cells, greater than any other body tissue (5000cells/ml vs. 100 - 1000 cells / ml in bone marrow).15Successful use of fat transfer techniques have beendescribed in plastic and reconstructive surgery, on vocalchords, for post - actinic dermatitis, etc. generating achange in the lipo - transfer paradigm.11The technique does not offer significant challenges fortrained brachytherapy experts. And provides theadvantage that no changes need to be made to treatmentplanning since the adipose transfer is conducted onceradiotherapy has been completed. Another importantadvantage is the low cost of the procedure, which onlyrequires commercially-available plastic surgery needles.Perhaps the biggest challenge remains generating ahomogenous distance between the prostate and therectum, particularly because injected fat will tend toshift away from the midline. To avoid this, it is importantnot to apply too much pressure on the transrectaltransducer, which would push fat delivery away fromthe midline. It is also convenient to introduce themidline graft first and only then inject into the sides,while controlling transducer positioning along bothplanes. Another potential source of difficulty arises frommanual needle introduction since which may fail tocoincide with grid holes. This series includes our"learning curve", which is why in some cases, lessdistance was achieved, especially at the prostate apexlevel. We included primary and rescue cases since ourmain objective was to evaluate technique feasibility aswell as radiotherapy influence on fat tissue viability, aresult not yet reported in the literature. In this series,reduced apex separation corresponded to early cases,probably due to poor technique or excessive pressure onthe transrectal transducer, which pushed injected fataway from the midline, to lateral areas of less resistance.It remains to be established whether transferred fatremains in situ with time, and whether it is modified ornot by radiotherapy exposure. Adipose stem cells areknown to generate new vessel formation after 48 hours.This neovascularization allows adipocyte andpre-adipocyte survival,16 although not all transferred fattissue remains stable, and some will undergotransformation to connective tissue. Histologyexamination of transferred fat has always been fromnon-irradiated tissue samples.17 We plan to conductbiopsies between 6 and 12 months of follow-up toestablish transferred tissue condition afterbrachytherapy. If prostate-rectum distance equal to orgreater than 10mm is maintained at 6 months, thisshould be sufficient to guarantee very low adverseclinical event rates, considering Iodine - 125 half - life is59.4 days.
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5. ConclusionAutologous fat transfer is a simple procedure forexperienced practitioners with low complication rates,allowing radiation dose escalation. Mean separationgenerated by our group after three months was: 9.6 mm(1.9 - 14.6 mm), 6.3mm (1.8 - 10.2 mm) and 5.4 mm (3.8- 7.2 mm) at prostate base, middle and apex, respectivelywith minimal complications These are encouragingresults although larger case series, with rectal volumedosimetry, as well as longer follow - up will be needed toestablish the true value of this procedure duringradiotherapy for primary or salvage prostate cancertreatment.
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